UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$188M |
| 2 |
Yelp
YELP
|
+$182M |
| 3 |
General Motors
GM
|
+$141M |
| 4 |
American Express
AXP
|
+$138M |
| 5 |
Comcast
CMCSA
|
+$116M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
eBay
EBAY
|
+$331M |
| 2 |
Crown Castle
CCI
|
+$303M |
| 3 |
Cardinal Health
CAH
|
+$204M |
| 4 |
Gilead Sciences
GILD
|
+$157M |
| 5 |
Apple
AAPL
|
+$150M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.6% |
| 2 | Healthcare | 13.9% |
| 3 | Technology | 13.4% |
| 4 | Industrials | 10.1% |
| 5 | Consumer Discretionary | 9.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SLH
1076
DELISTED
SOLERA HOLDINGS, INC. COM
SLH
| $3.17M | ﹤0.01% |
44,832
-531
| -1% | -$33.2K |
|
1077
Nektar Therapeutics
NKTR
$2.49B
| $3.15M | ﹤0.01% |
18,491
-16,549
| -47% | -$2.67M |
|
1078
MasTec
MTZ
$21.2B
| $3.13M | ﹤0.01% |
95,778
-2,192
| -2% | -$69.4K |
|
1079
Donaldson
DCI
$11.3B
| $3.12M | ﹤0.01% |
71,872
-2,200
| -3% | -$89.6K |
|
1080
Steris
STE
$22.2B
| $3.12M | ﹤0.01% |
64,848
-425
| -0.7% | -$19.4K |
|
1081
Reliance Steel & Aluminium
RS
$21.3B
| $3.11M | ﹤0.01% |
41,071
-917
| -2% | -$67.8K |
|
|
SGMO
1082
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $3.06M | ﹤0.01% |
220,598
+1,600
| +0.7% | +$18.4K |
|
1083
Community Health Systems
CYH
$410M
| $3.06M | ﹤0.01% |
94,315
-1,694
| -2% | -$58.2K |
|
1084
Calix
CALX
$2.39B
| $3.06M | ﹤0.01% |
317,300
+294,900
| +1,317% | +$3.16M |
|
1085
Stantec
STN
$8.31B
| $3.02M | ﹤0.01% |
97,378
-4,000
| -4% | -$121K |
|
|
DCT
1086
DELISTED
DCT Industrial Trust Inc.
DCT
| $3.01M | ﹤0.01% |
105,533
+10,375
| +11% | +$308K |
|
|
TIBX
1087
DELISTED
TIBCO SOFTWARE INC
TIBX
| $3M | ﹤0.01% |
133,372
+56,500
| +73% | +$1.38M |
|
1088
AtriCure
ATRC
$2.05B
| $2.98M | ﹤0.01% |
159,641
-2,427
| -1% | -$35.3K |
|
1089
Prosperity Bancshares
PB
$8.92B
| $2.97M | ﹤0.01% |
46,837
-15,394
| -25% | -$972K |
|
1090
Oil States International
OIS
$514M
| $2.97M | ﹤0.01% |
51,021
| – | – |
|
1091
Compass Minerals
CMP
$1.03B
| $2.96M | ﹤0.01% |
36,946
-334
| -0.9% | -$25K |
|
1092
CNO Financial Group
CNO
$5.15B
| $2.92M | ﹤0.01% |
165,092
-4,300
| -3% | -$68.9K |
|
|
HUB.B
1093
DELISTED
HUBBELL INC CL-B
HUB.B
| $2.9M | ﹤0.01% |
26,663
-4,536
| -15% | -$485K |
|
1094
SM Energy
SM
$6.87B
| $2.88M | ﹤0.01% |
34,644
-1,000
| -3% | -$85.3K |
|
|
VIRX
1095
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $2.86M | ﹤0.01% |
2,878
| – | – |
|
|
CYNO
1096
DELISTED
Cynosure, Inc. Class A
CYNO
| $2.86M | ﹤0.01% |
107,279
+96,990
| +943% | +$2.33M |
|
1097
Commerce Bancshares
CBSH
$8.54B
| $2.85M | ﹤0.01% |
114,055
-8,508
| -7% | -$209K |
|
1098
Patterson-UTI
PTEN
$3.86B
| $2.83M | ﹤0.01% |
111,747
-95,383
| -46% | -$2.28M |
|
|
TRQ
1099
DELISTED
Turquoise Hill Resources Ltd
TRQ
| $2.78M | ﹤0.01% |
84,184
-23,106
| -22% | -$778K |
|
|
PNNT
1100
Pennant Park Investment Corp
PNNT
$238M
| $2.77M | ﹤0.01% |
238,974
-2,484
| -1% | -$28.5K |
|
Similar funds
UBS AM's Q4 2013 Portfolio in Review
As of Q4 2013, UBS AM held 2,637 positions worth $87.5B, up 8.1% from $80.9B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
UBS AM's Q4 2013 filing shows 130 new, 1,010 increased, 1,128 reduced and 103 closed positions. Its largest new stake was Trip.com Group: 2,309,000 shares worth $57.3M. The largest sale was eBay, an estimated $331M.
By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Technology.
- UBS AM's largest Q4 2013 buy was Trip.com Group: 2,309,000 shares worth $57.3M.
- UBS AM added most to Regeneron Pharmaceuticals in Q4 2013, an estimated $188M increase.
- UBS AM's biggest Q4 2013 reduction was eBay, cutting an estimated $331M.
- UBS AM fully exited DELL INC in Q4 2013, selling an estimated $62.9M.
- UBS AM's ten largest holdings make up 14% of its $87.5B portfolio in Q4 2013.
- UBS AM opened 130 new positions and closed 103 in Q4 2013.
- UBS AM's portfolio value rose 8.1% quarter-over-quarter to $87.5B.
Based on UBS AM's 13F filing for Q4 2013, filed 31 Jan 2014.